Bolt Biotherapeutics, Inc. Shareholders' Equity
Bolt Biotherapeutics, Inc. (BOLT) had Shareholders' Equity of $12.64 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Parent $12.64M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $19.82M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $26.50M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $32.10M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $12.64M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $19.82M 10-Q · filed 2026-08-11 |
| 2025-12-31 | $26.50M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $32.10M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $38.84M 10-Q · filed 2026-08-11 |
| 2025-03-31 | $46.81M 10-Q · filed 2026-08-11 |
| 2024-12-31 | $57.20M 10-Q · filed 2026-08-11 |
| 2024-09-30 | $72.03M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $85.86M 10-Q · filed 2025-11-12 |
| 2024-03-31 | $104.16M 10-Q · filed 2025-08-14 |
| 2023-12-31 | $112.74M 10-K · filed 2026-03-12 |
| 2023-09-30 | $128.26M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $142.13M 10-Q · filed 2024-11-12 |
| 2023-03-31 | $157.69M 10-Q · filed 2024-08-13 |
| 2022-12-31 | $171.51M 10-K · filed 2025-03-24 |
| 2022-09-30 | $188.45M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $207.97M 10-Q · filed 2023-11-09 |
| 2022-03-31 | $228.39M 10-Q · filed 2023-08-07 |
| 2021-12-31 | $250.12M 10-K · filed 2024-03-21 |
| 2021-09-30 | $274.91M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $295.90M 10-Q · filed 2022-11-10 |
| 2021-03-31 | $303.25M 10-Q · filed 2022-08-10 |
| 2020-12-31 | -$104.95M 10-K · filed 2023-03-29 |
| 2020-09-30 | -$74.59M 10-Q · filed 2021-11-09 |
| 2020-06-30 | -$65.04M 10-Q · filed 2021-11-09 |
| 2020-03-31 | -$54.23M 10-Q · filed 2021-08-12 |
| 2019-12-31 | -$45.85M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |